Frequency and Clinical Significance of Renal and Bone Toxicity in HIV-infected Patients — ComorVIH  

Renal Toxicity Clinical Trial

Official title: Frequency and Clinical Significance of Renal and Bone Toxicity in HIV-infected Patients: Role of Classical Factors, HIV Infection, and Antiretroviral Therapy

Status Completed

Clinical Trial Summary

The purpose of this study is to determine the frequency of renal and bone toxicity in HIV infected patients receiving antiretroviral therapy, and the outcome in terms of treatment change or/and virological failure, in relation with the presence of classical factors, such as diabetes or hypertension, the role of HIV itself, because of chronic inflammation, and the effects of antiretroviral medication.

Clinical Trial Description

This is a retrospective cohort study involving 300 patients to determine the frequency of renal and bone comorbidities/toxicity in a large population of HIV-infected patients receiving antiretroviral therapy, in order to establish the differential role of classical factors, HIV infection, or antiretroviral therapy. ;

Study Design

Observational Model: Cohort, Time Perspective: Retrospective

Related Conditions & MeSH terms

• Renal Toxicity

• NCT number: NCT02116751
• Study type: Observational
• Source: Asociacion para el Estudio de las Enfermedades Infecciosas
• Status: Completed
• Phase: N/A
• Start date: April 2014
• Completion date: December 2014